Physician profile
Dexter Arrington
NPI 1861475121
$5,687.43
in general payments reported to CMS, 2019-2025
32 companies · $498 in 2025
The $498 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,584 · 2020: $183 · 2021: $1,016 · 2022: $1,037 · 2023: $973 · 2024: $397 · 2025: $498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,868.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,867.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $1,281.57 | 2019-2025 | Acessa Provu System, Coolseal Generator, Myosure Tissue Removal Device |
| Intuitive Surgical, INC. | $1,040.73 | 2019-2022 | |
| Acessa Health INC. | $564.06 | 2020-2021 | |
| Abbvie INC. | $545.88 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Coopersurgical, INC. | $351.12 | 2019-2025 | Paragard T 380a, Paragard T 380a, Mara Console |
| Aspira Women'S Health INC | $291.28 | 2021-2022 | |
| Organon LLC | $196.43 | 2022-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $153.92 | 2023-2025 | Myfembree, Gemtesa |
| Inspire Medical Systems, INC. | $150.00 | 2024 | Inspire |
| Cytyc Surgical Products, LLC | $114.78 | 2019 | |
| Myovant Sciences INC. | $97.10 | 2022 | |
| Exeltis, USA INC. | $90.00 | 2020-2025 | Slynd |
| Gynesonics, INC. | $89.02 | 2023-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Merck Sharp & Dohme LLC | $81.44 | 2019-2021 | |
| Medtronic, INC. | $77.87 | 2023 | Ligasure |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $65.30 | 2019 | |
| Pfizer INC. | $58.40 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $56.60 | 2024-2025 | |
| Astellas Pharma US INC | $55.06 | 2023-2025 | Veozah |
| Shield Therapeutics INC | $53.64 | 2022-2023 | Accrufer |
| Pacira Pharmaceuticals Incorporated | $46.53 | 2024 | Exparel |
| Ethicon US, LLC | $38.79 | 2023 | Stratafix, Ethicon |
| Scynexis, INC. | $30.40 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.87 | 2023 | |
| Exact Sciences Corporation | $22.71 | 2023 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $20.02 | 2022 | |
| Meditrina | $19.49 | 2023 | |
| Covidien Lp | $16.36 | 2019 | |
| Boston Scientific Corporation | $14.87 | 2019 | |
| Lupin INC. | $12.49 | 2019 | |
| Minerva Surgical, INC | $11.67 | 2019 | |
| Si-Bone, INC. | $10.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dexter Arrington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.